TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
THC

Tenet Healthcare Corporation

Healthcare · Medical Care Facilities

257.60$ -0.1% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios THC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
423.7 – – – 17.1 – 10.6 9.7 13.1 13.0 3.9 12.8
0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.5 0.3 0.4 0.6 0.8
7.8 4.3 3.5 – – – 151.4 8.6 4.7 4.9 3.0 4.3
1.0 0.9 0.8 0.8 0.9 1.0 1.0 1.1 1.0 1.1 1.1 1.3
9.5 8.8 7.7 8.8 6.6 8.5 6.9 6.0 6.4 6.4 3.3 6.3
– 16.3 – 3.1 4.1 7.0 1.5 9.7 16.8 4.9 11.1 7.1
-4.8% 6.1% -21.6% 32.2% 24.3% 14.3% 67.6% 10.3% 6.0% 20.5% 9.0% 14.0%
Margins
35.8% 35.9% 36.4% 35.4% 36.4% 36.3% 35.3% 37.3% 36.8% 38.0% 39.7% 82.3%
5.6% 5.8% 6.4% 5.8% 8.9% 8.3% 11.3% 14.7% 12.2% 12.2% 28.8% 16.1%
0.1% -0.8% -1.0% -3.7% 0.6% -1.2% 2.3% 4.7% 2.1% 3.0% 15.5% 6.6%
-1.5% 1.0% -1.6% 2.6% 2.4% 3.0% 16.3% 4.7% 1.7% 7.9% 5.4% 11.9%
Returns
1.8% -20.3% -46.0% – – – 1,425.0% 88.9% 36.0% 38.0% 76.7% 33.3%
0.1% -0.6% -0.8% -3.0% 0.5% -0.9% 1.5% 3.3% 1.5% 2.2% 11.1% 4.7%
Balance Sheet & Debt
11,614 13,302 14,539 14,326 14,415 14,489 13,273 13,282 14,221 13,774 10,358 10,288
6.6 7.2 7.0 8.0 5.9 6.7 5.2 3.6 4.6 4.1 1.5 2.3
3.6% 2.9% 1.7% -0.6% -0.5% -1.6% 0.1% 3.7% 4.2% 5.7% 14.4% 14.2%
18.1 19.8 36.6 – – – 561.4 15.2 13.2 9.3 3.2 3.1
Per Share
0.12 -1.41 -1.93 -7.00 1.00 -2.08 3.75 8.42 3.72 5.83 32.69 15.49
165.55 187.91 197.55 190.66 176.29 178.72 166.00 179.47 173.50 196.07 211.12 234.61
6.49 6.97 4.20 -1.46 -1.15 -3.59 0.26 9.47 10.33 15.34 42.61 46.46
-2.45 1.86 -3.19 4.90 4.16 5.44 26.98 8.38 2.90 15.49 11.40 27.85

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?